Antimicrobial resistance is the ability of micro-organisms to neutralize the effect of drugs produced to defeat them. It is a natural biological phenomenon but lately a variety of factors have contributed to accelerate these defences mechanisms, such as: inappropriate or abuse of therapeutic antibiotics in human and veterinary medicine; poor hygiene and infection prevention measures in healthcare settings and at farm level; or lack of new effective antimicrobial alternatives.
The ineffectiveness of drugs is causing direct severe effects such as longer illness, increased mortality, prolonged stays in hospitals, and lack of drug protection in operations and medical procedures, and increased costs. Combating antimicrobial resistance has become a global public health challenge.
The essence of the One Health approach to tackling AMR is in the understanding that in order to combat AMR appropriately and effectively, concerted collaborative efforts are necessary across the human health, veterinary medicine and environment sectors. It must involve partnerships between those working at the interface of multiple related disciplines, putting together action from veterinarians, physicians, epidemiologists, researchers in public health and ecology, in which reaching a consensus depends on political commitment.
The development of enhanced surveillance systems and prudent use of antimicrobials in human and veterinary medicine are two of the key areas for action of the EU policy against AMR.
At international level, the Union particularly wants to focus on implementation of commitments made on AMR in international fora, including the WHO Global Action Plan on AMR as well as in the OIE and FAO resolutions. Sustaining political momentum, focusing on next steps and increasing international awareness and cooperation are also important components to follow-up the conclusions of the high-level event on AMR that was held at the United Nations General Assembly in September 2016.
As one of the largest markets for agricultural products, the EU can play a major role by promoting its standards and measures for addressing AMR with its trade partners. The proposed training will therefore aim at strengthening the EU as 'stronger global actor', and at building on existing relationships and facilitating policy dialogue with the involved countries.
The Training Programme on Antimicrobial resistance non EU overall objectives are:
The course addresses the following topics:
The training course is mainly addressed to:
The overall objectives of the BTSF Training Programme on Antimicrobial Resistance are: